FindTrial
Sign In

The effect evaluation of vitamin D supplementation in the populations with pre-diabetes

The effect evaluation of vitamin D supplementation in the populations with pre-diabetes

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019719
Enrollment
Unknown
Registered
2018-11-25
Start date
2016-01-01
Completion date
Unknown
Last updated
2018-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Interventions

Group 1:Vitamin D3 10000u/M
Group 2:No

Sponsors

Beijing Luohe Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Prediabetes defined at the baseline visit by meeting two of the following three glycemic criterias: (1) FPG 5.5–6.9 mmol/L; (2) 2hPG after 75-g glucose load (7.7–11.0 mmol/L; (3) Hemoglobin A1c 5.7–6.4%; 2. Aged >30 years; 3. BMI 23 -40kg/m2.

Exclusion criteria

Exclusion criteria: Patients who have been diagnosed diabetes; Patients with hyperthyroidism, kidney stones and hypercalcemia; Patients who are taking drugs affecting blood glucose, blood calcium and kidney function(such as calcium, glucocorticoid, etc.) Patients who have had gastrointestinal surgery; Malignant tumor, severe hepatic and renal insufficiency and pregnancy

Design outcomes

Primary

MeasureTime frame
Incidence of diabetes;—

Secondary

MeasureTime frame
fasting blood-glucose;25(OH)D;—

Countries

China

Contacts

Public ContactBaoyu Zhang

Beijing Luohe Hospital, Capital Medical University

lhyynfm@126.com+86 18611693159

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026